Transvascular lipoprotein transport in patients with chronic renal disease.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 15200434)

Published in Kidney Int on July 01, 2004

Authors

Trine Krogsgaard Jensen1, Børge Grønne Nordestgaard, Bo Feldt-Rasmussen, Kurt Svarre Jensen, Jan Skov Jensen

Author Affiliations

1: Department of Nephrology and Endocrinology P, The National University Hospital, Copenhagen, Denmark.

Articles by these authors

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet (2011) 13.10

Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med (2008) 7.95

Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation (2004) 3.71

CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. J Clin Oncol (2008) 3.36

The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med (2004) 3.34

Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA (2008) 3.10

Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med (2012) 3.00

Increased risk of breast cancer associated with CHEK2*1100delC. J Clin Oncol (2006) 2.71

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial. Lancet (2010) 2.38

Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease. Kidney Int (2013) 2.08

Changes in leisure-time physical activity and risk of death: an observational study of 7,000 men and women. Am J Epidemiol (2003) 1.58

New-onset diabetes mellitus after kidney transplantation in Denmark. Clin J Am Soc Nephrol (2010) 1.53

High-degree atrioventricular block complicating ST-segment elevation myocardial infarction in the era of primary percutaneous coronary intervention. Europace (2012) 1.53

Hypercholesterolaemia and risk of coronary heart disease in the elderly: impact of age: the Copenhagen City Heart Study. Eur J Intern Med (2008) 1.50

Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals. JAMA Psychiatry (2013) 1.48

OPPORTUNITY™: a large-scale randomized clinical trial of growth hormone in hemodialysis patients. Nephrol Dial Transplant (2011) 1.44

Risk of stroke after coronary artery bypass grafting: effect of age and comorbidities. Stroke (2011) 1.43

Hemochromatosis mutations in the general population: iron overload progression rate. Blood (2003) 1.43

Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population. J Exp Med (2007) 1.29

Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. Cancer Res (2011) 1.27

Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. Blood (2002) 1.19

Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark. Clin J Am Soc Nephrol (2010) 1.19

New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. Hypertension (2005) 1.17

Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol (2003) 1.17

Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol (2012) 1.17

Intensity versus duration of walking, impact on mortality: the Copenhagen City Heart Study. Eur J Cardiovasc Prev Rehabil (2007) 1.16

Alcoholism and alcohol drinking habits predicted from alcohol dehydrogenase genes. Pharmacogenomics J (2007) 1.11

Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease. Nephrol Dial Transplant (2011) 1.06

Long-term physical activity in leisure time and mortality from coronary heart disease, stroke, respiratory diseases, and cancer. The Copenhagen City Heart Study. Eur J Cardiovasc Prev Rehabil (2006) 1.03

Myocardial strain analysis by 2-dimensional speckle tracking echocardiography improves diagnostics of coronary artery stenosis in stable angina pectoris. Circ Cardiovasc Imaging (2013) 1.03

Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease. Kidney Int (2012) 1.01

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels? Diabetologia (2014) 0.98

Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia. Intensive Care Med (2010) 0.98

The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9-36)a in an isolated rat heart. Pharmacol Res (2009) 0.94

Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the Copenhagen City Heart Study). Am J Cardiol (2013) 0.93

Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study. Scand J Infect Dis (2012) 0.93

Concordance and reproducibility between M-mode, tissue Doppler imaging, and two-dimensional strain imaging in the assessment of mitral annular displacement and velocity in patients with various heart conditions. Eur Heart J Cardiovasc Imaging (2013) 0.90

Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction. Eur Heart J (2006) 0.90

Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention. J Invasive Cardiol (2009) 0.90

Estimating glomerular filtration rate using the new CKD-EPI equation and other equations in patients with autosomal dominant polycystic kidney disease. Am J Nephrol (2009) 0.89

Substantial need for early diagnosis, rehabilitation and treatment of chronic obstructive pulmonary disease. Dan Med J (2012) 0.89

Resting heart rate is a predictor of mortality in COPD. Eur Respir J (2012) 0.87

Kidney transplantation improves arterial function measured by pulse wave analysis and endothelium-independent dilatation in uraemic patients despite deterioration of glucose metabolism. Nephrol Dial Transplant (2010) 0.86

Socioeconomic status and prognosis of COPD in Denmark. COPD (2014) 0.86

Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol (2011) 0.85

Flow-associated dilatory capacity of the brachial artery is intact in early autosomal dominant polycystic kidney disease. Am J Nephrol (2006) 0.85

Impact of hemoglobin on plasma pro-B-type natriuretic peptide concentrations in the general population. Clin Chem (2007) 0.85

Prognostic value of cardiac time intervals by tissue Doppler imaging M-mode in patients with acute ST-segment-elevation myocardial infarction treated with primary percutaneous coronary intervention. Circ Cardiovasc Imaging (2013) 0.84

Nanogen microelectronic chip for large-scale genotyping. Clin Chem (2004) 0.84

Atrial fibrillation in aortic stenosis--echocardiographic assessment and prognostic importance. Cardiovasc Ultrasound (2012) 0.84

Increased urinary orosomucoid excretion is not related to impaired renal function in patients with type 2 diabetes. J Diabetes Complications (2008) 0.84

Prognosis and treatment in patients admitted with acute myocardial infarction on weekends and weekdays from 1997 to 2009. Int J Cardiol (2012) 0.83

Tissue Doppler echocardiography reveals distinct patterns of impaired myocardial velocities in different degrees of coronary artery disease. Eur J Echocardiogr (2010) 0.83

Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation. BMC Nephrol (2012) 0.83

Cardiovascular morbidity in COPD: A study of the general population. COPD (2010) 0.83

No gender differences in prognosis and preventive treatment in patients with AMI without significant stenoses. Eur J Prev Cardiol (2011) 0.83

Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure. Eur J Heart Fail (2014) 0.83

Tissue Doppler echocardiography improves the diagnosis of coronary artery stenosis in stable angina pectoris. Eur Heart J Cardiovasc Imaging (2012) 0.83

Pre-diabetes and arterial stiffness in uraemic patients. Nephrol Dial Transplant (2009) 0.83

Usefulness of the myocardial performance index determined by tissue Doppler imaging m-mode for predicting mortality in the general population. Am J Cardiol (2011) 0.83

Mutation in apolipoprotein B associated with hypobetalipoproteinemia despite decreased binding to the low density lipoprotein receptor. J Biol Chem (2005) 0.82

Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.82

Obstetric nephrology: pregnancy in women with diabetic nephropathy--the role of antihypertensive treatment. Clin J Am Soc Nephrol (2012) 0.82

Polymorphisms in apolipoprotein B and risk of ischemic stroke. J Clin Endocrinol Metab (2007) 0.82

Increased orosomucoid in urine is an independent predictor of cardiovascular and all-cause mortality in patients with type 2 diabetes at 10 years of follow-up. J Diabetes Complications (2013) 0.81

Long-term prognosis in an ST-segment elevation myocardial infarction population treated with routine primary percutaneous coronary intervention: from clinical trial to real-life experience. Circ Cardiovasc Interv (2009) 0.81

Elevated plasma fibrinogen, psychological distress, antidepressant use, and hospitalization with depression: two large population-based studies. Psychoneuroendocrinology (2012) 0.81

The Angio-Seal™ femoral closure device allows immediate ambulation after coronary angiography and percutaneous coronary intervention. EuroIntervention (2011) 0.81

Elevated third-trimester haemoglobin A 1c predicts preterm delivery in type 1 diabetes. J Diabetes Complications (2008) 0.81

3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents. JACC Cardiovasc Interv (2012) 0.81

Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP. Heart (2012) 0.81

Microalbuminuria and obesity: impact on cardiovascular disease and mortality. Clin Endocrinol (Oxf) (2008) 0.81

Transvascular low-density lipoprotein transport in patients with diabetes mellitus (type 2): a noninvasive in vivo isotope technique. Arterioscler Thromb Vasc Biol (2002) 0.80

Plasma adiponectin before and after kidney transplantation. Transpl Int (2012) 0.79

Tissue Doppler echocardiography reveals impaired cardiac function in patients with reversible ischaemia. Eur J Echocardiogr (2011) 0.79

Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetes. J Diabetes Complications (2007) 0.79

Drug-eluting stents and bare metal stents in patients with NSTE-ACS: 2-year outcome from the randomised BASKET-PROVE trial. EuroIntervention (2014) 0.79

Plasma calprotectin predicts mortality in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Interv Cardiol (2010) 0.79

Higher prevalence of risk factors for type 2 diabetes mellitus and subsequent higher incidence in men. Eur J Intern Med (2007) 0.79

Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease. Int J Cardiol (2013) 0.78

Glucagon-like peptide 1--a cardiologic dimension. Trends Cardiovasc Med (2010) 0.78

Diagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation Societies. Transpl Int (2013) 0.78

Transendothelial exchange of low-density lipoprotein is unaffected by the presence of severe atherosclerosis. Cardiovasc Res (2004) 0.78

Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease. J Clin Endocrinol Metab (2014) 0.78

Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes--results from the BASKET PROVE trial. Int J Cardiol (2013) 0.78

OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients. Clin J Am Soc Nephrol (2008) 0.78

High levels of mannose-binding lectin are associated with lower pulse wave velocity in uraemic patients. BMC Nephrol (2014) 0.78

Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosis. Atherosclerosis (2003) 0.78

New Danish reference values for spirometry. Clin Respir J (2013) 0.78

Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Am Heart J (2012) 0.77